Treating migraine in the emergency department

BMJ

Volumn 336, Issue 7657, 2008, Pages 1320-

  Evans, Randolph W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CORTICOSTEROID; DEXAMETHASONE; NARCOTIC ANALGESIC AGENT; PLACEBO; TRIPTAN DERIVATIVE;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EDITORIAL; EMERGENCY CARE; EMERGENCY WARD; HUMAN; MEDICAL RESEARCH; MIGRAINE; NAUSEA; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; SYMPTOM; VOMITING;

ADRENAL CORTEX HORMONES; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; HUMANS; MIGRAINE DISORDERS;

EID: 46249113884     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39560.696748.80     Document Type: Editorial

References (11)

1. Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 2008; doi: 10.1136/bmj.39566.806725.BE.
2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; American Migraine Prevalence and Prevention (AMPP) Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9.
3. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American migraine prevalence and prevention study. Headache 2007;47:355-63.
4. Diener HC, Limmroth V. Specific acute migraine treatment: ergotamine and triptans. In: Lipton R, Bigal M, eds. Migraine and other headache disorders: tools and rules for diagnosis and treatment. Ontario: BC Decker, 2006:289-310.
5. Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008;70:1525-33.
6. Ducharme J. Canadian Association of Emergency Physicians guidelines for the acute management of migraine headache. J Emerg Med 1999;17:137-44.
7. Tomabene SV, Deutsch R, Davis DP, Chan TC, Vilke GM. Evaluating the use and timing of opioids for the treatment of migraine headaches in the emergency department. J Emerg Med 2008 Feb 13 [Epub ahead of print].
8. Friedman BW, Hochberg ML, Esses D, Grosberg BM, Rothberg D, Bernstein B, et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med 2008 Apr 1 [Epub ahead of print].
9. Hussain A, Young WB. Steroids and aseptic osteonecrosis (AON) in migraine patients. Headache 2007;47:600-4.
10. Goadsby PJ. Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era? Neurology 2008;70:1300-1.
11. Shapiro RE, Goadsby PJ. The long drought: the dearth of public funding for headache research. Cephalalgia 2007;27:991-4.